These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17509178)

  • 1. High coverage with HAART is required to substantially reduce the number of deaths from tuberculosis: system dynamics simulation.
    Atun RA; Lebcir RM; Drobniewski F; McKee M; Coker RJ
    Int J STD AIDS; 2007 Apr; 18(4):267-73. PubMed ID: 17509178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model.
    Atun RA; Lebcir RM; McKee M; Habicht J; Coker RJ
    Health Policy; 2007 May; 81(2-3):207-17. PubMed ID: 16854499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a decision support systems computer simulation model to examine HIV and tuberculosis: the Russian Federation.
    Lebcir RM; Choudrie J; Atun RA; Coker RJ
    Int J Electron Healthc; 2009; 5(1):14-32. PubMed ID: 19505866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis epidemics driven by HIV: is prevention better than cure?
    Currie CS; Williams BG; Cheng RC; Dye C
    AIDS; 2003 Nov; 17(17):2501-8. PubMed ID: 14600522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV on novel therapies for tuberculosis control.
    Sánchez MS; Lloyd-Smith JO; Porco TC; Williams BG; Borgdorff MW; Mansoer J; Salomon JA; Getz WM
    AIDS; 2008 May; 22(8):963-72. PubMed ID: 18453856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidrug-resistant tuberculosis in AIDS patients at the beginning of the millennium].
    Palmero D; Ritacco V; Ambroggi M; Poggi S; Güemes Gurtubay J; Alberti F; Waisman J
    Medicina (B Aires); 2006; 66(5):399-404. PubMed ID: 17137168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in perimortal conditions and mortality rates among HIV-infected patients.
    Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
    AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated tuberculosis in the era of HAART.
    Pozniak A
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):993-4. PubMed ID: 11092707
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.
    Murphy RA
    Clin Infect Dis; 2008 Jun; 46(11):1729-32. PubMed ID: 18426372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
    Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
    Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
    Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
    Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
    AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.
    Basu S; Orenstein E; Galvani AP
    J Infect Dis; 2008 Nov; 198(10):1502-13. PubMed ID: 18816192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.